Phase 0
50 Years
N/A
50 Years
N/A
Not Enrolling
Both
Prevention of Colorectal Cancer
Both
Prevention of Colorectal Cancer
Trial Information
Inclusion Criteria:
- All non-pregnant patients >50 years of age
Exclusion Criteria:
- The following will be specifically looked for, and result in patients not being
eligible for study enrollment:
- Use of non-steroidal anti-inflammatory drugs or glucocorticosteroids within 60
days of study entry.
- History of chronic IBD or prior pelvic radiation (inflammation distorts crypt
pattern).
- Intake of any selenium supplements within 60 days of study entry, including
vitamins.
- Patients with increased bleeding risk from biopsy protocol (i.e. renal failure,
decompensated cirrhosis, blood dyscrasia).
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Outcome Measure:
Reduction in ACF biomarkers
Outcome Time Frame:
6 months
Safety Issue:
No
Principal Investigator
Richard V Benya, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Illinois
Authority:
United States: Food and Drug Administration
Study ID:
2008-1122
NCT ID:
NCT01211561
Start Date:
December 2010
Completion Date:
December 2016
Related Keywords:
- Prevention of Colorectal Cancer
- Colorectal Neoplasms
Name | Location |
|---|---|
| University of Illinois at Chicago Medical Center | Chicago, Illinois 60612 |
